Martin Hansen

发表

Serotonin 2A Receptor Agonist Binding in the Human Brain with [11C]Cimbi-36

C. Svarer, G. Knudsen, S. Lehel, 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.

H. Bräuner‐Osborne, Martin Hansen, J. Kristensen, 2014, ACS chemical neuroscience.

Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT2A receptors, in mice

Martin Hansen, J. Kristensen, W. Fantegrossi, 2015, Psychopharmacology.

Correlating the Metabolic Stability of Psychedelic 5-HT2A Agonists with Anecdotal Reports of Human Oral Bioavailability

J. Kehler, C. Bundgaard, Martin Hansen, 2014, Neurochemical Research.

The selective 5-HT2A receptor agonist 25CN-NBOH: structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOH.

A. A. Jensen, H. Bräuner‐Osborne, Martin Hansen, 2020, Biochemical pharmacology.

Extensive rigid analogue design maps the binding conformation of potent N-benzylphenethylamine 5-HT2A serotonin receptor agonist ligands.

D. E. Nichols, M. Lill, J. McCorvy, 2013, ACS chemical neuroscience.

Accelerating preclinical PET-screening: reductive amination with [11C]methoxybenzaldehydes

G. Knudsen, S. Lehel, J. Madsen, 2014 .

Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands.

G. Knudsen, S. Lehel, H. D. Hansen, 2016, Nuclear medicine and biology.

Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A/2C partial agonists.

J. McCorvy, H. Bräuner‐Osborne, Martin Hansen, 2015, Bioorganic & medicinal chemistry.

Characterization of [11C]Cimbi-36 as an agonist PET radioligand for the 5-HT2A and 5-HT2C receptors in the nonhuman primate brain

Gitte Moos Knudsen, Anders Ettrup, Christer Halldin, 2014, NeuroImage.

Preclinical Safety Assessment of the 5-HT2A Receptor Agonist PET Radioligand [11C]Cimbi-36

Claus Svarer, Gitte Moos Knudsen, Anders Ettrup, 2013, Molecular Imaging and Biology.

Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT2A agonist PET tracers

Anders Ettrup, Nic Gillings, Matthias M. Herth, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

Radiosynthesis and Evaluation of 11C-CIMBI-5 as a 5-HT2A Receptor Agonist Radioligand for PET

Anders Ettrup, Nic Gillings, Gitte M. Knudsen, 2010, The Journal of Nuclear Medicine.

A prodrug approach involving in situ depot formation to achieve localized and sustained action of diclofenac after joint injection.

S. Larsen, C. Larsen, J. Østergaard, 2014, Journal of Pharmacy and Science.

Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT2A receptors, in mice

Martin Hansen, J. Kristensen, W. Fantegrossi, 2015, Psychopharmacology.